• Implantable Cardiac Pacemaker Market Competition by Manufacturers including Production,
Share, Revenue, Average Price, Manufacturing Base Distribution, Sales Area and Product Type.
• Implantable Cardiac Pacemaker Market Manufacturers Profiles/Analysis including Company
Basic Information, Manufacturing Base and Its Competitors.
• Implantable Cardiac Pacemaker Market Manufacturing Cost Analysis including Key Raw
Materials and Key Suppliers of Raw Materials.
• Industrial Chain, Sourcing Strategy and Downstream Buyers including Upstream Raw Materials
Sourcing and Downstream Buyers
• Marketing Strategy Analysis, Distributors/Traders including Marketing Channel, Market
Positioning and Distributors/Traders List.
• Market Effect Factors Analysis including Technology Progress/Risk, Consumer Needs/Customer
Preference Change and Economic/Political Environmental Change.
• Implantable Cardiac Pacemaker Market Forecast including Production, Consumption, Import
and Export Forecast by Type, Applications and Region.
• Research Findings and Conclusion
Introduction of Advanced Pacemaker Technologies is Expected to Drive Growth of the
Implantable Cardiac Pacemaker Market
Adoption of advanced technologies in cardiac pacemakers such as MRI safe-pacemakers,
pacemakers with improved battery life, delay the progression of persistent Atrial Fibrillation
(AF) in patients suffering from bradycardia and wireless automated technologies. This
advancements are gaining significant traction of various market players of implantable cardiac
pacemakers with affordable costs, which in turn are expected to drive growth of implantable
cardiac pacemakers market. For instance, in February 2017, Abbott received the Food and Drug
Administration (FDA) approval for its MR-conditional labeling for both of its products i.e.
Assurity MRI pacemaker and the Tendril MRI pacing lead. Furthermore, introduction of advance
technology such as wireless and automated pacemaker monitoring pacemakers are gaining
significant traction among healthcare providers.
Increasing Prevalence of Cardiovascular Disease is Expected to Drive Growth of Implantable
Cardiac Pacemaker Market
Increasing incidence of cardiovascular diseases is expected to boost growth of the implantable
cardiac pacemakers market over the forecast period. According to the Centers for Disease
Control and Prevention (CDC), August 2017 data findings, Atrial Fibrillation (AFib or AF) is
most common type of heart arrhythmia, which affected an estimated 2.7 to 6.1 million people
in the U.S. and the number is expected to increase in near future. Furthermore, Atrial